21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
Details for Australian Patent Application No. 2004288196 (hide)
International Classifications
Event Publications
27 April 2006 PCT application entered the National Phase
PCT publication WO2005/044988 Priority application(s): WO2005/044988
26 November 2009 Application Accepted
Published as AU-B-2004288196
28 January 2010 Alteration of Name
The name of the applicant has been altered to Merck Sharp & Dohme Corp.
25 March 2010 Standard Patent Sealed
24 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser